- Home
- GNTX vs ALKS Comparison
GNTX vs ALKS Comparison
Compare GNTX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTX
- ALKS
- Stock Information
- Founded
- GNTX 1974
- ALKS 1987
- Country
- GNTX United States
- ALKS Ireland
- Employees
- GNTX 5466
- ALKS N/A
- Industry
- GNTX Auto Parts:O.E.M.
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- GNTX Consumer Discretionary
- ALKS Health Care
- Exchange
- GNTX Nasdaq
- ALKS Nasdaq
- Market Cap
- GNTX 4.9B
- ALKS 4.5B
- IPO Year
- GNTX N/A
- ALKS 1991
- Fundamental
- Price
- GNTX $21.67
- ALKS $27.15
- Analyst Decision
- GNTX Buy
- ALKS Buy
- Analyst Count
- GNTX 7
- ALKS 12
- Target Price
- GNTX $27.50
- ALKS $38.55
- AVG Volume (30 Days)
- GNTX 2.7M
- ALKS 1.8M
- Earning Date
- GNTX 04-25-2025
- ALKS 05-01-2025
- Dividend Yield
- GNTX 2.23%
- ALKS N/A
- EPS Growth
- GNTX N/A
- ALKS 3.47
- EPS
- GNTX 1.76
- ALKS 2.17
- Revenue
- GNTX $2,313,314,333.00
- ALKS $1,557,632,000.00
- Revenue This Year
- GNTX $10.62
- ALKS N/A
- Revenue Next Year
- GNTX $7.15
- ALKS $4.38
- P/E Ratio
- GNTX $12.22
- ALKS $12.48
- Revenue Growth
- GNTX 0.61
- ALKS N/A
- 52 Week Low
- GNTX $20.28
- ALKS $22.90
- 52 Week High
- GNTX $35.33
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- GNTX 41.82
- ALKS 29.54
- Support Level
- GNTX $20.95
- ALKS $26.70
- Resistance Level
- GNTX $21.63
- ALKS $27.80
- Average True Range (ATR)
- GNTX 0.89
- ALKS 1.33
- MACD
- GNTX 0.08
- ALKS -0.14
- Stochastic Oscillator
- GNTX 45.57
- ALKS 22.49
About GNTX Gentex Corporation
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.